Category: Consumer goods
Quick infos Headquarters: Netherlands Trade prices Volume: Market Cap: 894.7M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: May 1, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 1, 2023 March 15, 2023 - / -0.8445- / 30.09MFebruary 27, 2023 0.15 / -0.8865102.7M / 19.42MBeat! November 2, 2022 -1.02 / -1.21.4M / 1.37MBeat! August 8, 2022 -0.84 / -0.996497K / 10.19MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 15, 2022 20.76 20.36 20.79
19.64
526.39K 1.86% Aug 12, 2022 20.38 19.78 20.48
19.76
1.43M 3.50% Aug 11, 2022 19.69 19.37 20.35
19.37
660.29K 0.82% Aug 10, 2022 19.53 19.10 19.71
18.80
760.31K 2.68% Aug 9, 2022 19.02 18.40 20.43
17.88
1.54M 2.04% Aug 8, 2022 18.64 21.03 21.18
16.75
3.74M -27.02% Aug 5, 2022 25.54 24.41 25.72
23.91
567.19K 2.16% Aug 4, 2022 25.00 24.92 25.19
24.60
439.13K 1.67% Aug 3, 2022 24.59 24.85 25.49
24.46
442.86K 1.91% Aug 2, 2022 24.13 23.78 24.37
23.58
380.25K 0.04% view more
QURE
News
UniQure stock is up after FDA lifts clinical hold on experimental gene therapy marketwatch.com Sep 27, 2022 12:03 pm
uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE) finance.yahoo.com Sep 27, 2022 11:31 am
UniQure's Stock Is Trading Higher As FDA Lifts Clinical Hold On Its Hemophilia B Gene Therapy Program finance.yahoo.com Sep 27, 2022 8:34 am
UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates finance.yahoo.com Sep 27, 2022 8:25 am
UniQure (QURE) Reports Q2 Loss, Lags Revenue Estimates finance.yahoo.com Sep 27, 2022 8:25 am
uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting finance.yahoo.com Sep 27, 2022 7:05 am
uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT) finance.yahoo.com Sep 27, 2022 7:05 am
uniQure to Participate in Upcoming Industry Conferences in September finance.yahoo.com Sep 6, 2022 7:05 am uniQure plunges 27% on Q2 revenue miss, postpones higher dose trial of Huntington’s disease therapy seekingalpha.com Aug 8, 2022 10:01 pm uniQure GAAP EPS of -$0.84 beats by $0.11, revenue of $0.5M misses by $8.71M seekingalpha.com Aug 8, 2022 8:35 pm
Why uniQure Stock Is Crashing Today fool.com Aug 8, 2022 11:53 am
uniQure N.V.'s (NASDAQ:QURE) Stock's On An Uptrend: Are Strong Financials Guiding The Market? finance.yahoo.com Aug 2, 2022 12:34 pm Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8% investors.com Jul 11, 2022 3:00 am
Is uniQure (NASDAQ:QURE) Using Too Much Debt? finance.yahoo.com Jul 3, 2022 9:05 am uniQure gains over 15% after trial data for Huntington’s disease therapy seekingalpha.com Jun 23, 2022 10:48 pm
UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial finance.yahoo.com Jun 23, 2022 2:05 pm
Mizuho Comments On UniQure's Upcoming Low-Dose Huntington's Gene Therapy Trial Data finance.yahoo.com Jun 13, 2022 11:41 am
uniQure Announces FDA Acceptance of Biologics License Application for Etranacogene Dezaparvovec under Priority Review finance.yahoo.com May 24, 2022 8:00 am
Things Look Grim For uniQure N.V. (NASDAQ:QURE) After Today's Downgrade finance.yahoo.com May 4, 2022 6:08 am
M&As in Spotlight With GSK Announcement: 3 Biotechs in Focus finance.yahoo.com Apr 14, 2022 10:03 am This company doesn't provide a dividend.
Key Persons Talk about uniQure NV below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 91 HOLD 9 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.